SCHEMBL7164341

SCHEMBL7164341

Cc1ccc(Cc2cncnc2N2CCCC(=O)C2)c(Cl)c1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE2A O00408 1/20 0.34
KIT P10721 1/20 0.33
KDM4E B2RXH2 2/20 0.33
HTT P42858 2/20 0.33
PDE3B Q13370 1/20 0.33
PDE3A Q14432 1/20 0.33
ALDH1A1 P00352 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
PKM P14618 2/20 0.31
MAPK1 P28482 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2D6 P10635 1/20 0.31
HSD17B10 Q99714 1/20 0.31
NPC1 O15118 1/20 0.31
LMNA P02545 1/20 0.31
RAB9A P51151 1/20 0.31
DGAT1 O75907 1/20 0.30
TP53 P04637 2/20 0.30
MAPT P10636 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7159348 0.90 HTT (0.33) PDE2AKDM4EHTTALDH1A1NPSR1
SCHEMBL7163401 0.89 ALDH1A1 (0.42) KDM4EHTTPDE3BPDE3AALDH1A1
SCHEMBL7164355 0.88 PDE3B (0.34) KITKDM4EHTTPDE3BPDE3A
SCHEMBL7159379 0.87 PIK3CA (0.36) PDE2AKDM4EHTTALDH1A1NPSR1
SCHEMBL7163517 0.85 RPS6KB1 (0.40) KITHTTALDH1A1NPSR1CYP3A4
SCHEMBL7159692 0.85 KIT (0.40) KITKDM4EHTTALDH1A1PKM
SCHEMBL5207346 0.84 HSP90AA1 (0.36) PDE3BPDE3A
SCHEMBL7160676 0.80 MAPK1 (0.39) KDM4EHTTPDE3BPDE3AALDH1A1
SCHEMBL7163194 0.78 TP53 (0.34) PDE2AKITPDE3BPDE3ATP53
SCHEMBL7159488 0.78 PDE3B (0.35) KITPDE3BPDE3ANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6583148-B1 Neurodegenerative or other neurological disorders; enhancing the effect of nerve growth factor; 2-Amino-5-(4-chlorophenoxy)-4-trans-4-hydroxycyclohexylamino) pyrimidine KRENITSKY PHARMACEUTICALS, INC. 2003-06-24 US claimed
US-6583148-B1 Neurodegenerative or other neurological disorders; enhancing the effect of nerve growth factor; 2-Amino-5-(4-chlorophenoxy)-4-trans-4-hydroxycyclohexylamino) pyrimidine KRENITSKY PHARMACEUTICALS, INC. 2003-06-24 US disclosed